David L. Rimm
- Oncology top 0.01%
- Molecular Biology top 0.1%
- Cancer Research top 0.05%
- Pulmonary and Respiratory Medicine top 0.1%
- Immunology top 0.1%
- Co-authors
- Robert L. CampMarisa Dolled‐FilhartKurt A. SchalperVamsidhar VelchetiHarriet M. KlugerRoy S. HerbstJon S. MorrowGina G. Chung
- Topics
- Cancer Immunotherapy and Biomarkers (138 papers)HER2/EGFR in Cancer Research (100 papers)Immunotherapy and Immune Responses (61 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesGreeceCanada
In The Last Decade
David L. Rimm
537 papers receiving 40.7k citations
Hit Papers
Peers
Comparison fields: 5 of 193
- Oncology 19.9k
- Molecular Biology 17.9k
- Cancer Research 8.2k
- Pulmonary and Respiratory Medicine 7.9k
- Immunology 7.0k
Countries citing papers authored by David L. Rimm
This map shows the geographic impact of David L. Rimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Rimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Rimm more than expected).
Fields of papers citing papers by David L. Rimm
This network shows the impact of papers produced by David L. Rimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Rimm. The network helps show where David L. Rimm may publish in the future.
Co-authorship network of co-authors of David L. Rimm
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Rimm. A scholar is included among the top collaborators of David L. Rimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Rimm. David L. Rimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 38 | |
| 3 | 41 | |
| 4 | 67 | |
| 5 | 225 | |
| 6 | 111 | |
| 7 | 103 | |
| 8 | 40 | |
| 9 | 162 | |
| 10 | 35 | |
| 11 | 111 | |
| 12 | 160 | |
| 13 | 31 | |
| 14 | 57 | |
| 15 | 129 | |
| 16 | 69 | |
| 17 | 29 | |
| 18 | 98 | |
| 19 | 90 | |
| 20 | 371 |
About David L. Rimm
David L. Rimm is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 547 papers that have together received 41.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (138 papers), HER2/EGFR in Cancer Research (100 papers) and Immunotherapy and Immune Responses (61 papers). The work is most often cited by research in Oncology (19.9k citations), Cancer Research (8.2k citations) and Immunology (7.0k citations). David L. Rimm has collaborated with scholars based in United States, Greece and Canada. Frequent co-authors include Robert L. Camp, Marisa Dolled‐Filhart, Kurt A. Schalper, Vamsidhar Velcheti, Harriet M. Kluger, Roy S. Herbst, Jon S. Morrow, Gina G. Chung, Lori A. Charette and Aaron J. Berger. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.